Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
risankizumab-rzaa 600 MG/10ML Soln 10 mL Vial (NDC 74501501) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 4, 2026 , from http://ppman.hank.ai/transparency/procedure/74501501/by-state?code_type=NDC
“risankizumab-rzaa 600 MG/10ML Soln 10 mL Vial (NDC 74501501) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/74501501/by-state?code_type=NDC. Accessed
November 4, 2026 .
“risankizumab-rzaa 600 MG/10ML Soln 10 mL Vial (NDC 74501501) by State,” HANK Price Transparency ,
accessed November 4, 2026 ,
http://ppman.hank.ai/transparency/procedure/74501501/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
74501501 — Risankizumab-rzaa 600 Mg/10ml Soln 10 Ml Vial
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$22,001
National median
$15,828 – $37,925
IQR (p25 – p75)
3
hospitals filing
3
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 74501501 (NDC), with interquartile range
State Median p25 p75
NJ $63,750 $28,171 $115,893
CA $23,339 $26 $27,306
OH $18,750 $15,828 $20,089